Dr. Manuel F. Camacho Jr., MD

Dr. Camacho practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Camacho's NPI, 1699955195, was assigned on November 13, 2007. Dr. Camacho graduated from Feinberg School of Medicine in 1974. Dr. Camacho holds Florida license 26655.

Dr. Camacho's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Camacho also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Dr. Camacho's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. Dmand AI also links Dr. Camacho to 1 breast imaging center, 1 physician office and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Camacho practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Camacho's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Camacho is board certified in urology by the American Board of Urology. Dr. Camacho is licensed in Florida.

Dmand AI lists enlarged prostate, erectile dysfunction, prostate cancer, urinary endoscopy, urine flow blockage and UTI among the conditions Dr. Camacho treats.

CMS data shows 413 Medicare services from Dr. Camacho across 9 procedure codes in 2024, for 66 Medicare patients. Medicare paid $48,199 for them.

CMS counts 66 Medicare patients who saw Dr. Camacho in 2024. The largest group is 75 to 84, with 23 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 61% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Camacho's median patient age at 73, with 13% women.

In 2024, Dr. Camacho wrote 253 Medicare Part D claims for 69 patients. 89% of them were for generic drugs. CMS names the drug for 173 of them, across 7 drugs with 11 or more claims each, at $57,993 in total drug cost. In 2023, CMS named 176 claims across 7 drugs.

Dmand AI links 4 papers to Dr. Camacho. The most frequent topics are Ureteral Obstruction and Urinary Catheterization. Dr. Camacho has published most often in Urology. Dr. Camacho's most frequent co-authors are Jorge L. Lockhart, MD and Victor Anthony Politano, DO.

CMS Open Payments shows 6 general payments to Dr. Camacho from 3 drug and device companies from 2016 to 2018. Education make up the largest share, 54% of the total. Janssen Pharmaceuticals, Inc paid the most, $155.

Dr. Camacho graduated from Feinberg School of Medicine in 1974.

Dr. Camacho is in network with 8 carriers, including Aetna, United Healthcare and Cigna. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.